Suchergebnisse - "Huang, Le"

PubPharm (7)

1

Rational application of EGFR-TKI adjuvant therapy in patients with completely resected stage IB-IIIA EGFR-mutant NSCLC : a systematic review and meta-analysis of 11 randomized controlled trials

enthalten in: BMC cancer | 2023

von Zhang, S. | Yi, X. | Huang, L. | +3

2

Rational application of EGFR-TKI adjuvant therapy in patients with completely resected stage IB-IIIA EGFR-mutant NSCLC: a systematic review and meta-analysis of 11 randomized controlled trials

enthalten in: BMC cancer | 2023

von Zhang, S. | Yi, X. | Huang, L. | +3

3

Rational application of EGFR-TKI adjuvant therapy in patients with completely resected stage IB-IIIA EGFR-mutant NSCLC: a systematic review and meta-analysis of 11 randomized controlled trials

enthalten in: BMC cancer | 2023

von Zhang, S. | Yi, X. | Huang, L. | +3

4

Clinical option of pemetrexed-based versus paclitaxel-based first-line chemotherapeutic regimens in combination with bevacizumab for advanced non-squamous non-small-cell lung cancer and optimal maintenance therapy : evidence from a meta-analysis of randomized control trials

enthalten in: BMC cancer | 2021

von Huang, L. | Cao, R. | Wang, Y. | +9

5

Clinical option of pemetrexed-based versus paclitaxel-based first-line chemotherapeutic regimens in combination with bevacizumab for advanced non-squamous non-small-cell lung cancer and optimal maintenance therapy: evidence from a meta-analysis of randomized control trials

enthalten in: BMC cancer | 2021

von Huang, L. | Cao, R. | Wang, Y. | +9

6

Short-term outcomes and safety of radiotherapy for immediate breast reconstruction with autologous flap transfer following breast-conserving surgery

enthalten in: BMC cancer | 2021

von Zhang, S. | Song, J. | Wang, Y. | +6

7

Short-term outcomes and safety of radiotherapy for immediate breast reconstruction with autologous flap transfer following breast-conserving surgery

enthalten in: BMC cancer | 2021

von Zhang, S. | Song, J. | Wang, Y. | +6

1
[1]